These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1381792)

  • 21. Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
    Udayachalerm W; Vechakarn O; Patumraj S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S306-13. PubMed ID: 11529349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nitrendipine and cilazapril alone or in combination on hemodynamics and regional blood flows in conscious spontaneously hypertensive rats.
    Clozel JP
    J Cardiovasc Pharmacol; 1988; 12(5):600-7. PubMed ID: 2468061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells.
    Powell JS; Rouge M; Müller RK; Baumgartner HR
    Basic Res Cardiol; 1991; 86 Suppl 1():65-74. PubMed ID: 1827985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
    Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S
    Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New, in Austria registered specialty drugs. Inhibace (cilazapril)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(6):178-82. PubMed ID: 1533738
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporin-induced hypertension in marmosets: a new model of hypertension sensitive to angiotensin-converting enzyme inhibition.
    Clozel JP; Fischli W
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):77-81. PubMed ID: 2475720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats.
    Young RH; Ding YA; Lee YM; Yen MH
    Am J Hypertens; 1995 Sep; 8(9):928-33. PubMed ID: 8541009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S; Heinz G; Kleinbloesem C; Korn A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
    Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW
    Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Function and structure of the vascular wall in experimental arterial hypertension. Effect of treatment].
    Michel JB; Tedgui A; Salzmann JL; Belmain J; Lévy B
    Nephrologie; 1989; 10(2):55-7. PubMed ID: 2677815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients.
    Fernandez PG; Bolli P; Lee C; Vasdev S
    Can J Cardiol; 1990; 6(1):9-14. PubMed ID: 2138049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
    Deget F; Brogden RN
    Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cilazapril on the cerebral circulation in spontaneously hypertensive rats.
    Clozel JP; Kuhn H; Hefti F
    Hypertension; 1989 Dec; 14(6):645-51. PubMed ID: 2531120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?
    Erb KA; Breithaupt K; Kleinbloesem CH; Wolf GK; Belz GG
    Clin Physiol Biochem; 1990; 8 Suppl 2():35-45. PubMed ID: 2151315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cilazapril, a novel angiotensin converting enzyme inhibitor, on the structure of pulmonary arteries of rats exposed to chronic hypoxia.
    Clozel JP; Saunier C; Hartemann D; Fischli W
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):36-40. PubMed ID: 1708054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in response of vascular angiotensin converting enzyme activity to cilazapril in SHR.
    Nakamura Y; Nakamura K; Nakamura K
    Clin Exp Hypertens A; 1987; 9(2-3):351-5. PubMed ID: 3038393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.
    Clozel JP
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):167S-174S. PubMed ID: 2527530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of 2.5 and 5 mg cilazapril versus placebo on daily blood pressure load.
    Poirier L; Pyzyk M; Provencher P; Lacourcière Y
    Am J Hypertens; 1991 Nov; 4(11):913-5. PubMed ID: 1838693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.